AbbVie traded at $159.39 this Wednesday May 22nd, decreasing $3.59 or 2.20 percent since the previous trading session. Looking back, over the last four weeks, AbbVie lost 5.95 percent. Over the last 12 months, its price rose by 11.84 percent. Looking ahead, we forecast AbbVie to be priced at 162.62 by the end of this quarter and at 157.93 in one year, according to Trading Economics global macro models projections and analysts expectations.